Top Markets
#1 Black Phoenix Black Phoenix +829.59%
#2 pipedog pipedog +41.28%
#3 PondCoin PondCoin +35.42%
#4 Bless Bless +35.40%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.74%
#6 SAFEcoin SAFEcoin +26.00%
#7 Beam Beam +24.62%
#8 Seeker Seeker +21.01%
#9 Magma Finance Magma Finance +20.64%
#10 YFSX YFSX +16.15%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
GH Research PLC GH Research PLC

GH Research PLC

GHRS
Rang in Aktien #6594
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to... GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
Aktienkurs
$28.53
Marktkapitalisierung
$1.96B
Veränderung (1 Tag)
-1.65%
Veränderung (1 Jahr)
109.32%
Land
IE
Handel GH Research PLC (GHRS)

Kategorie

Healthcare
Kursverlauf für GH Research PLC (GHRS)
Höchster Schlusskurs: $29.28 am 2026-08-01

Niedrigster Schlusskurs: $20.43 am 2021-06-01
Kursverlauf der Aktie von GH Research PLC von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 34.51%
2025 71.80%
2024 35.29%
2023 -44.18%
2022 -56.09%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 40.94%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.46%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 461.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH